Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers

Nature Biotechnology

Volumn 29, Issue 3, 2011, Pages 273-278

  Ling, Yibo ^a,b,c   Pong, Terrence ^a,d,e   Vassiliou, Christophoros C ^b,c   Huang, Paul L ^d,f   Cima, Michael J ^c,g  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC BIOMARKERS; CARDIOTOXICITY; CONTROL GROUPS; CUMULATIVE EXPOSURES; DOXORUBICIN; IMPLANTABLE DEVICES; INFARCT SIZE; MAGNETIC PARTICLE; MOLECULAR BIOMARKER; MONITORING DEVICE; MOUSE MODELS; MYOCARDIAL INFARCTION; PHYSIOLOGICAL LEVELS; RELAXATION PROPERTY; RELAXOMETRY; SENSOR RESPONSE; TIME POINTS;

AGGLOMERATION; IMPLANTS (SURGICAL); MAGNETIC RESONANCE; PHYSIOLOGICAL MODELS; SENSORS;

BIOMARKERS;

BIOLOGICAL MARKER; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; IMPLANT; IMPLANTABLE MAGNETIC RELAXATION SENSOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSOR;

ANIMALS; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; MAGNETICS; MICE; MYOCARDIAL ISCHEMIA; PROSTHESES AND IMPLANTS;

EID: 79952398729     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1780     Document Type: Article

References (25)

1. Gutterman, D.D. Silent myocardial ischemia. Circ. J. 73, 785-797 (2009).
2. Sheifer, S.E., Manolio, T.A. & Gersh, B.J. Unrecognized myocardial infarction. Ann. Intern. Med. 135, 801-811 (2001). (Pubitemid 33051264)
3. Ammar, K.A., Kors, J.A., Yawn, B.P. & Rodeheffer, R.J. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am. Heart J. 148, 277-284 (2004). (Pubitemid 39092792)
4. Shapiro, M.G., Atanasijevic, T., Faas, H., Westmeyer, G.G. & Jasanoff, A. Dynamic imaging with MRI contrast agents: quantitative considerations. Magn. Reson. Imaging 24, 449-462 (2006).
5. Daniel, K.D. et al. Multi-reservoir device for detecting a soluble cancer biomarker. Lab Chip 7, 1288-1293 (2007). (Pubitemid 47482974)
6. Kim, G.Y., Josephson, L., Langer, R. & Cima, M.J. Magnetic relaxation switch detection of human chorionic gonadotrophin. Bioconjug. Chem. 18, 2024-2028 (2007). (Pubitemid 350220004)
7. Taktak, S., Sosnovik, D., Cima, M.J., Weissleder, R. & Josephson, L. Multiparameter magnetic relaxation switch assays. Anal. Chem. 79, 8863-8869 (2007). (Pubitemid 350231692)
8. Tsourkas, A., Hofstetter, O., Hofstetter, H., Weissleder, R. & Josephson, L. Magnetic relaxation switch immunosensors detect enantiomeric impurities. Angew. Chem. Int. Edn Engl. 43, 2395-2399 (2004). (Pubitemid 39257738)
9. Perez, J.M., Josephson, L., O'Loughlin, T., Hogemann, D. & Weissleder, R. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816-820 (2002). (Pubitemid 34836759)
10. Perez, J.M., Josephson, L. & Weissleder, R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. ChemBioChem 5, 261-264 (2004). (Pubitemid 39257117)
11. Perez, J.M., O'Loughin, T., Simeone, F.J., Weissleder, R. & Josephson, L. DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J. Am. Chem. Soc. 124, 2856-2857 (2002). (Pubitemid 34249946)
12. Sun, E.Y., Weissleder, R. & Josephson, L. Continuous analyte sensing with magnetic nanoswitches. Small 2, 1144-1147 (2006). (Pubitemid 44369004)
13. Wunderbaldinger, P., Josephson, L. & Weissleder, R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad. Radiol. 9 Suppl 2, S304-S306 (2002). (Pubitemid 34857701)
14. Zhao, M., Josephson, L., Tang, Y. & Weissleder, R. Magnetic sensors for protease assays. Angew. Chem. Int. Edn Engl. 42, 1375-1378 (2003). (Pubitemid 36459976)
15. Daniel, K.D. et al. Implantable diagnostic device for cancer monitoring. Biosens. Bioelectron. 24, 3252-3257 (2009).
16. Jaffe, A.S., Babuin, L. & Apple, F.S. Biomarkers in acute cardiac disease: the present and the future. J. Am. Coll. Cardiol. 48, 1-11 (2006). (Pubitemid 44202476)
17. Tarnavski, O. et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol. Genomics 16, 349-360 (2004). (Pubitemid 38420055)
18. Thygesen, K., Alpert, J.S. & White, H.D. Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 50, 2173-2195 (2007). (Pubitemid 350123680)
19. Scherrer-Crosbie, M., Rodrigues, A.C.T., Hataishi, R. & Picard, M.H. Infarct size assessment in mice. Echocardiography 24, 90-96 (2007). (Pubitemid 46044654)
20. Bello, D. et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J. Am. Coll. Cardiol. 45, 1104-1108 (2005). (Pubitemid 40432446)
21. Roes, S.D. et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am. J. Cardiol. 100, 930-936 (2007). (Pubitemid 47368098)
22. Takemura, G. & Fujiwara, H. Doxorubicin-induced cardiomyopathy: from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49, 330-352 (2007). (Pubitemid 46295436)
23. Robert, J. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors. Cardiovasc. Toxicol. 7, 135-139 (2007). (Pubitemid 47339860)
24. Wallace, K.B. et al. Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol. Pathol. 32, 106-121 (2004). (Pubitemid 38249998)
25. Josephson, L., Tung, C.H., Moore, A. & Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10, 186-191 (1999). (Pubitemid 29147720)